Lysine

Pea Protein Market Size to Grow USD 7.7 Billion by 2028 at a CAGR of 11.9% | Valuates Reports

Retrieved on: 
Thursday, January 18, 2024

BANGALORE, India, Jan. 18, 2024 /PRNewswire/ -- Pea Protein Market is Segmented by Type (Low Purity Pea Protein Isolate (75%-80%), Medium Purity Pea Protein Isolate (80%-85%), High Purity Pea Protein Isolate (>85%)), by Application (Sports Nutrition Food, Energy Drinks, Health Food, Pet Food ): Global Opportunity Analysis and Industry Forecast, 2024-2030.

Key Points: 
  • BANGALORE, India, Jan. 18, 2024 /PRNewswire/ -- Pea Protein Market is Segmented by Type (Low Purity Pea Protein Isolate (75%-80%), Medium Purity Pea Protein Isolate (80%-85%), High Purity Pea Protein Isolate (>85%)), by Application (Sports Nutrition Food, Energy Drinks, Health Food, Pet Food ): Global Opportunity Analysis and Industry Forecast, 2024-2030.
  • The Global Pea Protein Market size is projected to grow from USD 1.7 Billion in 2022 to USD 7.7 Billion by 2028 at a CAGR of 11.9% during the forecast period.
  • The popularity of plant-centric lifestyles, driven by ethical, environmental, and health considerations, has increased demand for plant-based protein substitutes such as pea protein.
  • With a market share of more than 70%, Medium Purity Pea Protein Isolate (80%–85%) is the leading product category.

Pea Protein Market Size to Grow USD 7.7 Billion by 2028 at a CAGR of 11.9% | Valuates Reports

Retrieved on: 
Thursday, January 18, 2024

BANGALORE, India, Jan. 18, 2024 /PRNewswire/ -- Pea Protein Market is Segmented by Type (Low Purity Pea Protein Isolate (75%-80%), Medium Purity Pea Protein Isolate (80%-85%), High Purity Pea Protein Isolate (>85%)), by Application (Sports Nutrition Food, Energy Drinks, Health Food, Pet Food ): Global Opportunity Analysis and Industry Forecast, 2024-2030.

Key Points: 
  • BANGALORE, India, Jan. 18, 2024 /PRNewswire/ -- Pea Protein Market is Segmented by Type (Low Purity Pea Protein Isolate (75%-80%), Medium Purity Pea Protein Isolate (80%-85%), High Purity Pea Protein Isolate (>85%)), by Application (Sports Nutrition Food, Energy Drinks, Health Food, Pet Food ): Global Opportunity Analysis and Industry Forecast, 2024-2030.
  • The Global Pea Protein Market size is projected to grow from USD 1.7 Billion in 2022 to USD 7.7 Billion by 2028 at a CAGR of 11.9% during the forecast period.
  • The popularity of plant-centric lifestyles, driven by ethical, environmental, and health considerations, has increased demand for plant-based protein substitutes such as pea protein.
  • With a market share of more than 70%, Medium Purity Pea Protein Isolate (80%–85%) is the leading product category.

Origin Agritech Provides Business Updates and Answers Questions from Investors

Retrieved on: 
Tuesday, November 21, 2023

BEIJING, Nov. 21, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided investors with a business update and provided preliminary financial results for fiscal year 2023.

Key Points: 
  • Dr. Gengchen Han, Chairman and CEO of Origin Agritech, commented, "I would like to provide an overview of Origin Agritech's recent accomplishments and our ambitious plans for the future.
  • The past year has been marked by a series of significant milestones for Origin Agritech.
  • "Earlier this year, our triple-stack trait corn, featuring BFL4-2, was selected for inclusion in the national demo plot.
  • "Looking ahead, I am very optimistic and excited about the future of Origin Agritech.

Lygos Appoints Van Walsem as COO and Elevates Weber to CBO

Retrieved on: 
Tuesday, October 24, 2023

Lygos, Inc., a sustainable specialty chemicals company, announced today that it appointed Johan Van Walsem to the role of Chief Operating Officer, and promoted Rich Weber to Chief Business Officer, both reporting to Eric Steen, CEO.

Key Points: 
  • Lygos, Inc., a sustainable specialty chemicals company, announced today that it appointed Johan Van Walsem to the role of Chief Operating Officer, and promoted Rich Weber to Chief Business Officer, both reporting to Eric Steen, CEO.
  • Weber will be responsible for the planning and execution of commercial and business development activities.
  • Van Walsem returns as COO after serving as President and COO of Sierra Energy Corporation.
  • Weber joined Lygos in October of 2022 as the Sr. Vice President of Business Development.

Hemp, Inc. Reports: Growing Legalization of Industrial Hemp Driving Global Demand for Hemp

Retrieved on: 
Thursday, September 28, 2023

LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.

Key Points: 
  • LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.
  • The recent release of a comprehensive research report, Global Industrial Hemp Market (2023-2031) , says the global industrial hemp market is forecast to grow to $134.6 billion by 2030.
  • As one of the most rapidly growing plants on the planet, hemp is used to make a variety of products.
  • With the “growing legalization of industrial hemp farming around the world, the demand for industrial hemp has been exponential.

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease

Retrieved on: 
Thursday, September 14, 2023

PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of ADEL-Y01 for the treatment of Alzheimer's disease (AD).

Key Points: 
  • PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of ADEL-Y01 for the treatment of Alzheimer's disease (AD).
  • Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain.
  • "The IND clearance by the FDA represents a major achievement for us, especially in light of our first candidate entering into clinical trials," said Seung-Yong Yoon, M.D., CEO of ADEL.
  • "We are enthusiastic about commencing the clinical trial, as it brings us closer to providing therapeutic solutions for the patients grappling with tauopathies including AD."

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Friday, September 8, 2023

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Friday, September 8, 2023

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

ZXCHEM USA presents Revolutionary New Manufacturing Process for Plant Proteins in the US and Canadian Markets

Retrieved on: 
Wednesday, September 6, 2023

We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.

Key Points: 
  • We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.
  • HydroRice™ PA80 is 100% rice protein while HydroPR™ 80 is a 40/60 blend of rice and pea protein.
  • Both products are manufactured with a revolutionary new process that does not use enzymes or hydrolyzation to change the protein functionality.
  • Anhui Shunxin has assigned ZXCHEM USA as the exclusive distributor for the US and Canadian markets.

Global Lysine Research Report 2023-2028: Growing Healthcare Awareness Drives Demand - Nutrient-Rich Food and Medicinal Value Boost Market Prospects

Retrieved on: 
Wednesday, July 26, 2023

The market is being driven by increasing demand in various end-user industries, including animal feed, food, and healthcare.

Key Points: 
  • The market is being driven by increasing demand in various end-user industries, including animal feed, food, and healthcare.
  • Factors such as growing meat consumption, expansion of the cattle industry, and rising demand for functional food ingredients are contributing to the market's revenue growth.
  • Moreover, significant investments in research and development activities to enhance production capacity further bolster the market's prospects.
  • The growing global population, coupled with the increasing consumption of meat, is expected to drive the growth of global lysine market.